These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26727301)

  • 21. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.
    Solomon SD; Claggett B; Desai AS; Packer M; Zile M; Swedberg K; Rouleau JL; Shi VC; Starling RC; Kozan Ö; Dukat A; Lefkowitz MP; McMurray JJ
    Circ Heart Fail; 2016 Mar; 9(3):e002744. PubMed ID: 26915374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heart failure: another new PARADIGM in treatment for heart failure?
    Geach T
    Nat Rev Cardiol; 2015 Jan; 12(1):4. PubMed ID: 25445135
    [No Abstract]   [Full Text] [Related]  

  • 23. Prospective Comparison of ARNi with ACE-I to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF): paragon of a study or further investigation paramount?
    Krum H
    Circulation; 2015 Jan; 131(1):11-2. PubMed ID: 25411157
    [No Abstract]   [Full Text] [Related]  

  • 24. Combined angiotensin receptor/neprilysin inhibitors: a review of the new paradigm in the management of chronic heart failure.
    Macdonald PS
    Clin Ther; 2015 Oct; 37(10):2199-205. PubMed ID: 26386501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Neprilysin Inhibitors in Heart Failure.
    Salazar Adum JP; Arora R
    Am J Ther; 2017; 24(6):e737-e743. PubMed ID: 26580582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic developments in the therapy of heart failure: lessons to be learned.
    Parker JD
    Eur Heart J; 2015 Aug; 36(30):1952-4. PubMed ID: 26088390
    [No Abstract]   [Full Text] [Related]  

  • 27. Angiotensin-Neprilysin Inhibition as a Paradigm for All?
    Vaduganathan M; Desai AS
    Curr Cardiol Rep; 2016 Nov; 18(11):115. PubMed ID: 27747488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Sacubitril/Valsartan, a First-in-Class, Angiotensin Receptor Neprilysin Inhibitor (ARNI): Potential Uses in Hypertension, Heart Failure, and Beyond.
    Kario K
    Curr Cardiol Rep; 2018 Jan; 20(1):5. PubMed ID: 29374807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-Analysis of Efficacy of Sacubitril/Valsartan in Heart Failure With Preserved Ejection Fraction.
    Salah HM; Fudim M; Al'Aref SJ; Khan MS; Almarzooq ZI; Devabhaktuni SR; Mentz RJ; Butler J; Greene SJ
    Am J Cardiol; 2021 Apr; 145():165-168. PubMed ID: 33529619
    [No Abstract]   [Full Text] [Related]  

  • 30. Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands: A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic Guidelines.
    Ramos IC; Versteegh MM; de Boer RA; Koenders JMA; Linssen GCM; Meeder JG; Rutten-van Mölken MPMH
    Value Health; 2017 Dec; 20(10):1260-1269. PubMed ID: 29241885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paradigm-HF: a Paradigm Shift in Heart Failure Treatment?
    Correia LC; Rassi A
    Arq Bras Cardiol; 2016 Jan; 106(1):77-9. PubMed ID: 26815651
    [No Abstract]   [Full Text] [Related]  

  • 32. Sacubitril/Valsartan (Entresto): The Next Blockbuster Medication?
    Wachholtz CD; Hayes WJ
    S D Med; 2015 Nov; 68(11):510-1. PubMed ID: 26689034
    [No Abstract]   [Full Text] [Related]  

  • 33. Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.
    Srivastava PK; Claggett BL; Solomon SD; McMurray JJV; Packer M; Zile MR; Desai AS; Rouleau JL; Swedberg K; Fonarow GC
    JAMA Cardiol; 2018 Dec; 3(12):1226-1231. PubMed ID: 30484837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart failure therapy: what should clinicians believe?
    Fang JC
    JAMA; 2012 Nov; 308(20):2144-6. PubMed ID: 23188032
    [No Abstract]   [Full Text] [Related]  

  • 35. [No available].
    Rioux JD
    Perspect Infirm; 2016; 13(2):58. PubMed ID: 27156290
    [No Abstract]   [Full Text] [Related]  

  • 36. Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF.
    Balmforth C; Simpson J; Shen L; Jhund PS; Lefkowitz M; Rizkala AR; Rouleau JL; Shi V; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    JACC Heart Fail; 2019 Jun; 7(6):457-465. PubMed ID: 31078482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The PARAGON-HF trial: missed opportunity or first personalized therapy?].
    Senni M; Di Tano G
    G Ital Cardiol (Rome); 2020 Feb; 21(2):93-95. PubMed ID: 32051630
    [No Abstract]   [Full Text] [Related]  

  • 38. Angiotensin receptor/neprilysin inhibitor-a breakthrough in chronic heart failure therapy: summary of subanalysis on PARADIGM-HF trial findings.
    Książczyk M; Lelonek M
    Heart Fail Rev; 2020 May; 25(3):393-402. PubMed ID: 31713710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context.
    D'Angiolella LS; Cortesi PA; Pitotti C; Ritrovato D; Mantovani LG; Senni M
    Eur J Heart Fail; 2017 Nov; 19(11):1551-1553. PubMed ID: 28849615
    [No Abstract]   [Full Text] [Related]  

  • 40. Factors Associated With Noncompletion During the Run-In Period Before Randomization and Influence on the Estimated Benefit of LCZ696 in the PARADIGM-HF Trial.
    Desai AS; Solomon S; Claggett B; McMurray JJ; Rouleau J; Swedberg K; Zile M; Lefkowitz M; Shi V; Packer M
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.